FARMINGTON, Conn., May 14, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new reports on RNA interference (RNAi) and its relationship with peripheral markets:
RNA Interference (RNAi)
Global Industry Analysts' new RNA Interference (RNAi) market research report provides annual estimates and forecasts for drug discovery and target validation, reagents, and siRNA synthesis. This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million, and provides separate analytics for the US, Canada, Japan, Europe, Asia-Pacific, and the Rest of the World. Annual RNAi estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided. The report includes profiles of 135 companies including many key and niche players.
An Executive Summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/go240220-rna-interference-rnai.html
RNAi - technologies, markets and companies
While the most well-known use for RNAi reagents is in research, this market partially overlaps with drug discovery and therapeutic development. Areas of therapeutic applications include virus infections, cancer, genetic disorders and neurological diseases. Jain Pharmabiotech's new RNAi Market research report examines this developing category, identifying and analyzing 161 companies involved in developing RNAi technologies. Half of these supply reagents and technologies, others use the technologies for drug discovery. Out of these, 33 are developing RNAi-based therapeutics and 30 are involved in microRNAs.
Various RNAi -based products are currently in clinical trials with no marketed products to date, and many of the related patents are still pending. This report describes those RNAi technologies, along with design and methods of manufacture of siRNA reagents. These include chemical synthesis by in-vitro transcription and use of plasmid or viral vectors. Other approaches to RNAi include DNA-directed RNAi (ddRNAi) that is used to produce dsRNA inside the cell, which is cleaved into siRNA by the action of Dicer, a specific type of RNAse III. MicroRNAs are derived by processing of short hairpins that can inhibit the mRNAs. Expressed interfering RNA (eiRNA) is used to express dsRNA intracellularly from DNA plasmids.
A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/jai70930-rnai.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE Global Information, Inc.|
Copyright©2010 PR Newswire.
All rights reserved